D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 95 Citations 29,915 219 World Ranking 4803 National Ranking 2688

Overview

What is he best known for?

The fields of study he is best known for:

  • Cancer
  • Surgery
  • Internal medicine

Surgery, Radiation therapy, Pancreaticoduodenectomy, Pancreatic cancer and Pancreatic disease are his primary areas of study. His Surgery research integrates issues from Internal medicine and Adenocarcinoma. His Adenocarcinoma study combines topics in areas such as Neoadjuvant therapy, Survival analysis and Oncology.

His studies deal with areas such as Gemcitabine, Primary tumor and Performance status as well as Radiation therapy. His Pancreaticoduodenectomy research includes elements of Clinical pathway, Perioperative, Retrospective cohort study and Vein. His research in Pancreatic cancer intersects with topics in Preoperative care, Radiology and General surgery.

His most cited work include:

  • Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial. (1009 citations)
  • Borderline Resectable Pancreatic Cancer: Definitions, Management, and Role of Preoperative Therapy (600 citations)
  • Effect of Laparoscopic-Assisted Resection vs Open Resection of Stage II or III Rectal Cancer on Pathologic Outcomes: The ACOSOG Z6051 Randomized Clinical Trial (590 citations)

What are the main themes of his work throughout his whole career to date?

Peter W.T. Pisters mainly focuses on Surgery, Internal medicine, Radiation therapy, Cancer and Pancreaticoduodenectomy. His Surgery study combines topics from a wide range of disciplines, such as Radiology and Sarcoma. His work deals with themes such as Gastroenterology and Oncology, which intersect with Internal medicine.

His Cancer research is multidisciplinary, incorporating elements of Stage, Proportional hazards model and Lymph node. His Pancreaticoduodenectomy research is multidisciplinary, incorporating perspectives in Superior mesenteric artery, Perioperative, Capecitabine and Vein. In his study, Carcinoma is inextricably linked to Pancreatectomy, which falls within the broad field of Pancreatic cancer.

He most often published in these fields:

  • Surgery (58.30%)
  • Internal medicine (36.44%)
  • Radiation therapy (26.32%)

What were the highlights of his more recent work (between 2010-2019)?

  • Internal medicine (36.44%)
  • Oncology (23.08%)
  • Neoadjuvant therapy (16.60%)

In recent papers he was focusing on the following fields of study:

Peter W.T. Pisters mainly investigates Internal medicine, Oncology, Neoadjuvant therapy, Pancreaticoduodenectomy and Pancreatic cancer. His Internal medicine study typically links adjacent topics like Gastroenterology. Peter W.T. Pisters has included themes like Superior mesenteric artery, Surgery, Carcinoma, Neoplasm Recurrence and Chemoradiotherapy in his Neoadjuvant therapy study.

Peter W.T. Pisters interconnects Colorectal cancer and Radiology in the investigation of issues within Surgery. His Pancreatic cancer study improves the overall literature in Cancer. His research in Lymph node focuses on subjects like Lymph, which are connected to Radiation therapy.

Between 2010 and 2019, his most popular works were:

  • Effect of Laparoscopic-Assisted Resection vs Open Resection of Stage II or III Rectal Cancer on Pathologic Outcomes: The ACOSOG Z6051 Randomized Clinical Trial (590 citations)
  • Response of borderline resectable pancreatic cancer to neoadjuvant therapy is not reflected by radiographic indicators (335 citations)
  • Borderline Resectable Pancreatic Cancer: Need for Standardization and Methods for Optimal Clinical Trial Design (220 citations)

In his most recent research, the most cited papers focused on:

  • Cancer
  • Internal medicine
  • Surgery

Peter W.T. Pisters spends much of his time researching Surgery, Neoadjuvant therapy, Pancreatic cancer, Internal medicine and Pancreaticoduodenectomy. His Surgery research incorporates elements of Open Resection, Colorectal cancer and GiST. The study incorporates disciplines such as Chemoradiotherapy, Pancreatectomy and Adenocarcinoma in addition to Neoadjuvant therapy.

Peter W.T. Pisters usually deals with Pancreatic cancer and limits it to topics linked to Gastroenterology and Fluorouracil and Dose fractionation. Peter W.T. Pisters works on Internal medicine which deals in particular with Chemotherapy. Vein and Survival rate is closely connected to Radiology in his research, which is encompassed under the umbrella topic of Pancreaticoduodenectomy.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial.

Ronald P. DeMatteo;Karla V. Ballman;Cristina R. Antonescu;Robert G. Maki.
The Lancet (2009)

1509 Citations

Effect of Laparoscopic-Assisted Resection vs Open Resection of Stage II or III Rectal Cancer on Pathologic Outcomes: The ACOSOG Z6051 Randomized Clinical Trial

James Fleshman;Megan Branda;Daniel J. Sargent;Anne Marie Boller.
JAMA (2015)

834 Citations

Borderline Resectable Pancreatic Cancer: Definitions, Management, and Role of Preoperative Therapy

Gauri R. Varadhachary;Eric P. Tamm;James L. Abbruzzese;Henry Q. Xiong.
Annals of Surgical Oncology (2006)

802 Citations

Borderline resectable pancreatic cancer: the importance of this emerging stage of disease.

Matthew H.G. Katz;Peter W.T. Pisters;Douglas B. Evans;Charlotte C. Sun.
Journal of The American College of Surgeons (2008)

761 Citations

Preoperative Gemcitabine-Based Chemoradiation for Patients With Resectable Adenocarcinoma of the Pancreatic Head

Douglas B. Evans;Gauri R. Varadhachary;Christopher H. Crane;Charlotte C. Sun.
Journal of Clinical Oncology (2008)

749 Citations

Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas.

F. R. Spitz;J. L. Abbruzzese;Jeffrey E Lee;Peter W Pisters.
Journal of Clinical Oncology (1997)

623 Citations

Pancreaticoduodenectomy with vascular resection: margin status and survival duration

Jennifer F. Tseng;Chandrajit P. Raut;Jeffrey E. Lee;Peter W.T. Pisters.
Journal of Gastrointestinal Surgery (2004)

602 Citations

Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma

Chandrajit P. Raut;Jennifer F. Tseng;Jennifer F. Tseng;Charlotte C. Sun;Huamin Wang.
Annals of Surgery (2007)

600 Citations

Desmoid Tumor: Prognostic Factors and Outcome After Surgery, Radiation Therapy, or Combined Surgery and Radiation Therapy

Matthew T. Ballo;Gunar K. Zagars;Alan Pollack;Peter W.T. Pisters.
Journal of Clinical Oncology (1999)

554 Citations

Preoperative Gemcitabine and Cisplatin Followed by Gemcitabine-Based Chemoradiation for Resectable Adenocarcinoma of the Pancreatic Head

Gauri R. Varadhachary;Robert A. Wolff;Christopher H. Crane;Charlotte C. Sun.
Journal of Clinical Oncology (2008)

483 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Peter W.T. Pisters

Alessandro Gronchi

Alessandro Gronchi

University of Milan

Publications: 127

Douglas B. Evans

Douglas B. Evans

Medical College of Wisconsin

Publications: 125

Markus W. Büchler

Markus W. Büchler

University Hospital Heidelberg

Publications: 92

Christopher L. Wolfgang

Christopher L. Wolfgang

New York University

Publications: 87

Murray F. Brennan

Murray F. Brennan

Memorial Sloan Kettering Cancer Center

Publications: 85

Joseph M. Herman

Joseph M. Herman

Johns Hopkins University School of Medicine

Publications: 83

Raphael E. Pollock

Raphael E. Pollock

The Ohio State University

Publications: 78

Claudio Bassi

Claudio Bassi

University of Verona

Publications: 78

Jaffer A. Ajani

Jaffer A. Ajani

The University of Texas MD Anderson Cancer Center

Publications: 78

Jason B. Fleming

Jason B. Fleming

The University of Texas MD Anderson Cancer Center

Publications: 77

Massimo Falconi

Massimo Falconi

Vita-Salute San Raffaele University

Publications: 76

Timothy M. Pawlik

Timothy M. Pawlik

The Ohio State University Wexner Medical Center

Publications: 76

Herbert J. Zeh

Herbert J. Zeh

University of Pittsburgh

Publications: 75

Jeffrey E. Lee

Jeffrey E. Lee

The University of Texas MD Anderson Cancer Center

Publications: 74

Robert A. Wolff

Robert A. Wolff

The University of Texas MD Anderson Cancer Center

Publications: 67

Paolo G. Casali

Paolo G. Casali

University of Milan

Publications: 65

Trending Scientists

Katsuro Inoue

Katsuro Inoue

Osaka University

Boyang Liu

Boyang Liu

University of Maryland, College Park

Siegmar Diele

Siegmar Diele

Martin Luther University Halle-Wittenberg

Virinder S. Parmar

Virinder S. Parmar

City University of New York

David A. Clayton

David A. Clayton

Howard Hughes Medical Institute

Thomas Dresselhaus

Thomas Dresselhaus

University of Regensburg

Paulino Gómez-Puertas

Paulino Gómez-Puertas

Spanish National Research Council

Yasuo Mori

Yasuo Mori

Kyoto University

Christopher J. Poulsen

Christopher J. Poulsen

University of Michigan–Ann Arbor

Gislaine Z. Réus

Gislaine Z. Réus

Universidade do Extremo Sul Catarinense

Ashesh D. Mehta

Ashesh D. Mehta

Feinstein Institute for Medical Research

Peter L. Stern

Peter L. Stern

University of Manchester

Kaiping Peng

Kaiping Peng

Tsinghua University

Abhijit Guha

Abhijit Guha

University of Toronto

Robert D. Truog

Robert D. Truog

Harvard University

Geoffrey Wall

Geoffrey Wall

University of Waterloo

Something went wrong. Please try again later.